CBLI

Cleveland BioLabs, Inc. Common Stock NASDAQ Capital Market
$3.51
Open:High:Low:Close:
Range:
Volume:
Market: Extended-hours
CBLI
Cleveland BioLabs, Inc. Common Stock 73 High Street Buffalo NY, 14203 http://www.cbiolabs.com
Cleveland BioLabs Inc is a biopharmaceutical company developing novel approaches to activate immune system & address medical needs. Its proprietary platform of toll-like immune receptor activators are used in radiation, oncology immunotherapy & vaccine.
  • CEO: Yakov Kogan
  • Employees: 19
  • Sector: Healthcare
  • Industry: Biotechnology
Latest Stocks Posts
Card image
Card image
Card image
CBLI News
Latest news about the CBLI